A sweet potato
@yamphotography.bsky.social
Reposted by A sweet potato
I have quite the topic for the #MedSkyDebate this weekend.
Do you use Chat GTP and how has it affected your practise??
ChatGTP did this infographic.
Is AI bad for us or can we use it to assist us?
Pro’s and Con’s.
This should be the best debate!!
Do you use Chat GTP and how has it affected your practise??
ChatGTP did this infographic.
Is AI bad for us or can we use it to assist us?
Pro’s and Con’s.
This should be the best debate!!
August 8, 2025 at 11:26 AM
I have quite the topic for the #MedSkyDebate this weekend.
Do you use Chat GTP and how has it affected your practise??
ChatGTP did this infographic.
Is AI bad for us or can we use it to assist us?
Pro’s and Con’s.
This should be the best debate!!
Do you use Chat GTP and how has it affected your practise??
ChatGTP did this infographic.
Is AI bad for us or can we use it to assist us?
Pro’s and Con’s.
This should be the best debate!!
Reposted by A sweet potato
#ANZCAPresident David Story presenting the new ANZCA guidelines for periop management of GLP1-RAs at #AucklandCitySymposium. Note the recommendation for 24 hour liquid diet pre-op.
#JAFA @anzca.bsky.social #anaesthesia
#JAFA @anzca.bsky.social #anaesthesia
March 28, 2025 at 8:37 PM
#ANZCAPresident David Story presenting the new ANZCA guidelines for periop management of GLP1-RAs at #AucklandCitySymposium. Note the recommendation for 24 hour liquid diet pre-op.
#JAFA @anzca.bsky.social #anaesthesia
#JAFA @anzca.bsky.social #anaesthesia
March 29, 2025 at 10:24 AM
Reposted by A sweet potato
Early days, but another exciting application of vaccine technology.
And a tough one for antivaxx crowd.
Vaccine shows promise against aggressive breast cancer medicine.washu.edu/news/vaccine....
And a tough one for antivaxx crowd.
Vaccine shows promise against aggressive breast cancer medicine.washu.edu/news/vaccine....
Vaccine shows promise against aggressive breast cancer | WashU Medicine
Clinical trial targeted recurrence of hard-to-treat triple-negative breast cancer
medicine.washu.edu
December 6, 2024 at 12:34 AM
Early days, but another exciting application of vaccine technology.
And a tough one for antivaxx crowd.
Vaccine shows promise against aggressive breast cancer medicine.washu.edu/news/vaccine....
And a tough one for antivaxx crowd.
Vaccine shows promise against aggressive breast cancer medicine.washu.edu/news/vaccine....